Istituto Tumori Fondazione G. Pascale IRCCS

Naples, Naples 80131

0 studies enrolling now · 2 studies all time

What they study most

Metastatic Breast Cancer, Ovarian Cancer

Studies at this site

• A Study of Prexasertib (LY2606368) in Platinum-Resistant or Refractory Recurrent Ovarian Cancer — Completed
• A Study of Abemaciclib (LY2835219) in Participants With HR+, HER2- Advanced Breast Cancer — Withdrawn before enrolling